Card image cap
ISM-1 new target protein for treating chronic lung diseases

A  lung-resident protein, called isthmin 1 (ISM1), which is critical for restraining inflammation in a healthy lung by selectively eliminating the pro-inflammatory type of AMs, could be a potential target for developing a very promising biologic drug to treat COPD. A recent study, carried out by Dr Ge Ruowen, an associate professor at NUS Biological Sciences, and team, discovered this novel property of a protein found in human lungs which could lead to the development of biologic drugs that can potentially be used to treat COPD.

Content by Future Medicine

Disclaimer :
The author(s)' thoughts and opinions in this article are their own and do not necessarily reflect DocMode's viewpoint. The article is in no way created or edited by DocMode.


Supported by Koye Pharmaceuticals

Submit a Comment